Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 12/2022

Inhalt (28 Artikel)

Integrative oncology—the best from one world

  • Open Access
  • Editorial

Jutta Hübner

A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma

  • Original Article – Cancer Research

An-an Li, Fan Li, Min Lan, Yu Zhang, Dong Xie, Mei-ying Yan

Aberrant MEK5 signalling promotes clear cell renal cell carcinoma development via mTOR activation

  • Original Article – Cancer Research

Fangzhou Li, Xufeng Peng, Jiale Zhou, Qi Chen, Yonghui Chen

Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma

  • Original Article – Cancer Research

Bo Hong, Yi Li, Ran Yang, ShuYang Dai, Yong Zhan, Wen-Bo Zhang, Rui Dong

Inhibition of angiogenesis and tumor progression of MK-0429, an integrin αvβ3 antagonist, on oral squamous cell carcinoma

  • Open Access
  • Original Article – Cancer Research

Takayuki Nakagawa, Kouji Ohta, Takako Naruse, Miyuki Sakuma, Syohei Fukada, Nao Yamakado, Misaki Akagi, Kazuki Sasaki, Chieko Niwata, Shigehiro Ono, Tomonao Aikawa

CFTR reduces the proliferation of lung adenocarcinoma and is a strong predictor of survival in both smokers and non-smokers

  • Open Access
  • Original Article – Cancer Research

Qingyang Xiao, Stefania Koutsilieri, Despoina-Christina Sismanoglou, Volker M. Lauschke

Influencing factors of lung cancer patients' participation in shared decision-making: a cross-sectional study

  • Original Article – Cancer Research

Ying Wang, Jinna Zhang, Bo Hu, Jizhe Wang, Laixiang Zhang, Xiaohua Li, Xiuli Zhu

Prognostic significance of MATR3 in stage I and II non-small cell lung cancer patients

  • Original Article – Cancer Research

Justyna Durślewicz, Anna Klimaszewska-Wiśniewska, Jakub Jóźwicki, Paulina Antosik, Kamil Kozerawski, Dariusz Grzanka, Marcin Braun

Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer

  • Open Access
  • Original Article – Cancer Research

Thomas Kolben, Lena Müller, Sarah Meister, Lucia Keilmann, Christina Buschmann, Fabian Trillsch, Alexander Burges, Bastian Czogalla, Sophie Mitter, Elisa Schmoeckel, Stefanie Corradini, Sven Mahner, Udo Jeschke, Mirjana Kessler, Susanne Beyer

Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4+ T cells in melanomas

  • Open Access
  • Original Article – Cancer Research

Xuedan Du, Jinting Wu, Ye Zhao, Bin Wang, Xiaobo Ding, Qiuyan Lin, Yingyu Chen, Jinduo Zhao, Lixiao Liu, Xiaolu Mao, Zhen Fang, Chunhong Zhang, Wenfeng Li

Apalutamide and autophagy inhibition in a xenograft mouse model of human prostate cancer

  • Open Access
  • Original Article – Cancer Research

Daniel Eberli, Benedikt Kranzbühler, Lukas Prause, Valentin Baumgartner, Sheryl Preda, Rosa Sousa, Fabienne Lehner, Souzan Salemi

Synergistic antitumor effect of a penicillin derivative combined with thapsigargin in melanoma cells

  • Original Article – Cancer Research

Yanina Bellizzi, Patricia G. Cornier, Carina M. L. Delpiccolo, Ernesto G. Mata, Viviana Blank, Leonor P. Roguin

Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis

  • Original Article – Cancer Research

Chenlu Wu, Jiafei Ying, Mei Dai, Jing Peng, Danhua Zhang

The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer

  • Open Access
  • Original Article – Cancer Research

Jette Riecks, Arianna Parnigoni, Balázs Győrffy, Ludwig Kiesel, Alberto Passi, Davide Vigetti, Martin Götte

T helper cell-mediated epitranscriptomic regulation via m6A RNA methylation bridges link between coronary artery disease and invasive ductal carcinoma

  • Original Article – Cancer Research

Sudeshna Rakshit, Jithin S. Sunny, Melvin George, Luke Elizabeth Hanna, K. V. Leela, Koustav Sarkar

Prognostic impact of the number of peri-tumoral alveolar macrophages in patients with stage I lung adenocarcinoma

  • Original Article – Cancer Research

Osamu Noritake, Keiju Aokage, Ayako Suzuki, Kenta Tane, Tomohiro Miyoshi, Joji Samejima, Toyohumi Yoshikawa, Shawhay Charles Murata, Tokiko Nakai, Masahiro Tsuboi, Genichiro Ishii

The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma

  • Original Article – Cancer Research

Zhenchang Sun, Wenjuan Wan, Xudong Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Feifei Nan, Hui Yu, Yu Chang, Jiaqin Yan, Zhaoming Li, Fangfang Cui, Jurui Ge, Yaqin Duo XiaXu, Xia Xu, Xiaorui Fu, Mingzhi Zhang

Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors

  • Open Access
  • Original Article – Cancer Research

Daniela Doege, Melissa S. Y. Thong, Lena Koch-Gallenkamp, Heike Bertram, Andrea Eberle, Bernd Holleczek, Alice Nennecke, Ron Pritzkuleit, Annika Waldmann, Sylke R. Zeissig, Hermann Brenner, Volker Arndt

Overexpression of splicing factor poly(rC)-binding protein 1 elicits cycle arrest, apoptosis induction, and p73 splicing in human cervical carcinoma cells

  • Original Article – Cancer Research

Yuhong Chen, Zhihui Dou, Xiaohua Chen, Dapeng Zhao, Tuanjie Che, Wei Su, Tao Qu, Taotao Zhang, Caipeng Xu, Huiweng Lei, Qiang Li, Hong Zhang, Cuixia Di

Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression

  • Original Article – Cancer Research

Shengshu Li, Xiaoxin Lu, Dongyang Zheng, Weizong Chen, Yuzhu Li, Fang Li

Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition

  • Open Access
  • Original Article – Cancer Research

Joanna Kapeleris, Juliana Müller Bark, Shanon Ranjit, Derek Richard, Ian Vela, Kenneth O’Byrne, Chamindie Punyadeera

Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs

  • Original Article – Cancer Research

Xiaokang Zhang, Shishuo Sun, Yangna Miao, Yifan Yuan, Wanxin Zhao, Hailong Li, Xiaohuan Wei, Chao Huang, Xiaolei Hu, Bixi Wang, Heng Xu, Wei Zhang, Xiaoge Gao, Jingyuan Song, Junnian Zheng, Qing Zhang

Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping

  • Original Article – Cancer Research

Subhajit Chatterjee, Ajit Kumar Dhal, Subarno Paul, Saptarshi Sinha, Biswajit Das, Somya Ranjan Dash, Chanakya Nath Kundu

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

  • Original Article – Clinical Oncology

Emre Yekedüz, Deniz Tural, İsmail Ertürk, Serdar Karakaya, Cihan Erol, Özlem Ercelep, Çağatay Arslan, Özlem Nuray Sever, Saadettin Kılıçkap, Nihan Şentürk Öztaş, Ahmet Küçükarda, Orçun Can, Berna Öksüzoğlu, Mehmet Ali Şendur, Nuri Karadurmuş, Yüksel Ürün

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

  • Original Article – Clinical Oncology

Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş, Elif Berna Köksoy, Naziyet Köse, Bala Başak Öven, Başak Oyan Uluç, Atike Gökçen Demiray, Dilek Erdem, Bilgin Demir, Nazım Serdar Turhal, Necdet Üskent, Sinem Akbaş, Fatih Selçukbiricik, Ali İnal, Ahmet Bilici, Ömer Fatih Ölmez, Devrim Çabuk, Çağlar Ünal, Mutlu Hızal, Mehmet Ali Nahit Şendur, Mustafa Korkmaz, Nuri Karadurmuş, İsmail Ertürk, Sema Sezgin Göksu, Ali Murat Tatlı, Deniz Can Güven, Saadettin Kılıçkap, Nail Paksoy, Adnan Aydıner, Havva Yeşil Çınkır, Özlem Özkul, Akın Öztürk, Sevinç Ballı, Yasemin Kemal, Atike Pınar Erdoğan, Özlem Er, Perran Fulden Yumuk, Ahmet Demirkazık

Neu im Fachgebiet Onkologie

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.